Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device

References

• WHO Fact Sheet [last accessed 15 May 2013]. http://www.who.int/mediacentre/factsheets/fs310/en/
   Google Scholar
• Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics–2013 Update: A Report From the American Heart Association. Circulation 2013;127:e6–e245
   PubMed Web of Science ®Google Scholar
• Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, et al. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435–1443
   PubMed Web of Science ®Google Scholar
• Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241–2251
   PubMed Web of Science ®Google Scholar
• Birks EJ, Yacoub MH, Banner NR, Khaghani A. The role of bridge to transplantation: Should LVAD patients be transplanted? Curr Opin Cardiol 2004;19:148–153
   PubMed Web of Science ®Google Scholar
• Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, Banner NR, Khaghani A, Yacoub MH. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355:1873–1884
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Timothy Baldwin J, Young JB. Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 2013;32:141–156
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Third INTERMACS Annual Report: The evolution of destination therapy in the United States. J Heart Lung Transplant 2011;30:115–123
   PubMed Web of Science ®Google Scholar
• Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, Russell SD, Conte JV, Aaronson KD, McGee EC Jr, et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: A prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011;57:1890–1898
   PubMed Web of Science ®Google Scholar
• Lietz K. Destination therapy: Patient selection and current outcomes. J Card Surg 2010;25:462–471
   PubMed Web of Science ®Google Scholar
• Lahpor J, Khaghani A, Hetzer R, Pavie A, Friedrich I, Sander K, Strüber M. European results with a continuous-flow ventricular assist device for advanced heart failure patients. Eur J Cardiothorac Surg 2010;37:357–361
   PubMed Web of Science ®Google Scholar
• Crow S, John R, Boyle A, Shumway S, Liao K, Colvin-Adams M, Toninato C, Missov E, Pritzker M, Martin C, et al. Gastrointestinal bleeding rates in recipients of non-pulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 2009;137:208–215
   PubMed Web of Science ®Google Scholar
• Stern DR, Kazam J, Edwards P, Maybaum S, Bello RA, D'Alessandro DA, Goldstein DJ. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg 2010;25:352–356
   PubMed Web of Science ®Google Scholar
• Hu J, Mondal NK, Sorensen EN, Cai L, Fang HB, Griffith BP, Wu ZJ. Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices. J Heart Lung Transplant 2014;33:71–79
   PubMed Web of Science ®Google Scholar
• Ferroni P, Vazzana N, Riondino S, Cuccurullo C, Guadagni F, Davì G. Platelet function in health and disease: From molecular mechanisms, redox considerations to novel therapeutic opportunities. Antioxid Redox Signal 2012;17:1447–1485
   PubMed Web of Science ®Google Scholar
• Lopez JJ, Salido GM, Gómez-Arteta E, Rosado JA, Pariente JA. Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J Thromb Haemost 2007;5:1283–1291
   PubMed Web of Science ®Google Scholar
• Yeh JJ, Tsai S, Wu DC, Wu JY, Liu TC, Chen A. P-selectin-dependent platelet aggregation and apoptosis may explain the decrease in platelet count during Helicobacter pylori infection. Blood 2010;115:4247–4253
   PubMed Web of Science ®Google Scholar
• Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, Steidley DE, Ewald GA, Sundareswaran KS, Farrar DJ, Slaughter MS, et al. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 2012;5:241–248
   PubMed Web of Science ®Google Scholar
• Crow S, Chen D, Milano C, Thomas W, Joyce L, Piacentino V 3rd, Sharma R, Wu J, Arepally G, Bowles D, et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 2010;90:1263–1269
   PubMed Web of Science ®Google Scholar
• Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 2010;3:675–681
   PubMed Web of Science ®Google Scholar
• Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancini D. Acquired von Willebrand syndrome after continuousflow mechanical device support contributes to a high prevalence of bleeding during longterm support and at the time of transplantation. J Am Coll Cardiol 2010;56:1207–1213
   PubMed Web of Science ®Google Scholar
• Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol 2009;53:2162–2167
   PubMed Web of Science ®Google Scholar
• Geisen U, Heilmann C, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C, Budde U, Zieger B. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 2008;33:679–684
   PubMed Web of Science ®Google Scholar
• Mehra MR, Stewart GC, Uber PA. The vexing problem of thrombosis in long-term mechanical circulatory support. J Heart Lung Transplant 2014;33:1--11
   Google Scholar
• Leytin V. Apoptosis in the anucleate platelet. Blood Rev 2012;26:51–63
   PubMed Web of Science ®Google Scholar
• Gyulkhandanyan AV, Mutlu A, Freedman J, Leytin V. Markers of platelet apoptosis: Methodology and applications. J Thromb Thrombolysis 2012;33:397–411
   PubMed Web of Science ®Google Scholar